Neoadjuvant Treatment With Intravitreal Avastin for Large Uveal Melanomas
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
To examine the response of intravitreal Avastin in causing a clinically significant reduction in uveal melanoma tumor size (base height and volume).
conclusion of study
United States: Institutional Review Board
|Memorial Sloan Kettering Cancer Center||New York, New York 10021|